الصفحة الرئيسية>>Signaling Pathways>> Others>>Dipivefrin (hydrochloride)

Dipivefrin (hydrochloride)

رقم الكتالوجGC43476

Dipivefrin (هيدروكلوريد) (Dipivefrine hydrochloride) هو دواء أولي مضاد للزرق الذي يتحلل إلى المركب الفعال ، الإبينفرين ، بواسطة إسترات في القرنية.

Products are for research use only. Not for human use. We do not sell to patients.

Dipivefrin (hydrochloride) التركيب الكيميائي

Cas No.: 64019-93-8

الحجم السعر المخزون الكميّة
25mg
93٫00
متوفر
50mg
148٫00
متوفر
100mg
232٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Dipivefrin is a prodrug of epinephrine that is hydrolyzed by cholinesterase and other esterases in the cornea to epinephrine. It reduces the density of cultured bovine primary trabecular meshwork cells (IC50 = 115 µM). Additionally, it induces an elongated, fibroblast-like morphology and disrupts the actin cytoskeleton in bovine primary trabecular meshwork cells when used at a concentration of 103 µM. In cultured bovine corneal endothelial cells, dipivefrin (28 µM) enhances calcium signaling and induces cytotoxicity. Dipivefrin also suppresses primary human corneal keratinocyte proliferation when used at a concentration of 280 µM. Formulations containing dipivefrin have been used alone and in combination with β-adrenergic receptor antagonists for the treatment of glaucoma.

مراجعات

Review for Dipivefrin (hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Dipivefrin (hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.